Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204). (Q37280737)
Jump to navigation
Jump to search
scientific article published on 22 June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204). |
scientific article published on 22 June 2009 |
Statements
1 reference
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204). (English)
1 reference
Bart Barlogie
1 reference
Andrzej J Jakubowiak
1 reference
Brian G M Durie
1 reference
Mohamad A Hussein
1 reference
Vanessa Bolejack
1 reference
Jeffrey A Zonder
1 reference
John J Crowley
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference